Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Salvarani, C.
space
  arrow  Hunder, G. G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF COMMUNICATION

The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern

right arrow Carlo Salvarani; Sherine E. Gabriel; W. Michael O'Fallon; and Gene G. Hunder

1 August 1995 | Volume 123 Issue 3 | Pages 192-194

Objective: To investigate trends in the incidence of giant cell arteritis over a 42-year period in Olmsted County, Minnesota.

Design: Population-based incidence study.

Setting: Olmsted County, Minnesota.

Methods: All incidence cases of giant cell arteritis first diagnosed between 1950 and 1991 were identified using the unified record system at Mayo Clinic. Age- and sex-specific incidence rates were calculated using the number of incidence cases as the numerator and population estimates as the denominator. Overall rates were age-and sex-adjusted to the 1980 United States white population. The annual incidence rates were graphically illustrated using a 3-year centered moving average.

Results: Between 1950 and 1991, 125 Olmsted County residents (103 women and 22 men) were diagnosed with giant cell arteritis. The age- and sex-adjusted incidence per 100 000 persons 50 years of age or older was 17.8 (95% CI, 14.7 to 21.0); incidence was significantly higher in women (24.2 [CI, 19.5 to 28.9]) than in men (8.2 [CI, 4.8 to 11.6]). Age-specific incidence rates increased with age (P < 0.0001). The annual incidence rates increased significantly over the study period (P = 0.002) and appear to have clustered in five peak periods, which occurred about every 7 years. A significant calendar-time effect was identified; it predicted an increase in incidence of 2.6% (CI, 0.9% to 4.3%) every 5 years.

Conclusions: Our observation of a regular cyclic pattern in incidence rates over time supports the hypothesis of an infectious cause for giant cell arteritis. Similar studies in other populations are needed to confirm our findings.


The cause of giant cell arteritis is unknown. Many investigators have suggested that environmental factors, such as infectious agents, exposure to sunlight, and contact with birds may be involved in the pathogenesis of this condition [1, 2]. Population-based studies that provide the incidence rate of a disease over time can provide clues about etiologic or environmental factors that influence the risk for the disease. The incidence of giant cell arteritis has already been determined for the population of Olmsted County, Minnesota, from 1950 to 1985 [3]. We determined the incidence from 1986 to 1991 and analyzed the trends in incidence rates over 42 years to generate hypotheses about factors that may be related to the pathogenesis of giant cell arteritis.


Methods
space
up arrowTop
dotMethods
down arrowResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

The details of our epidemiologic methods have been described previously [4]. Our unique medical records linkage system allows ready access to the medical records of all health care providers for the population of Olmsted County, Minnesota, including the Mayo Clinic and its affiliated hospitals; the Olmsted Medical Group and Olmsted Community Hospital; local nursing homes; and the few private practitioners. All medical records (inpatient and outpatient) of Olmsted County residents that showed a surgical index entry of temporal or occipital artery biopsy or a medical diagnosis of giant cell arteritis between 1986 and 1991 were reviewed, and information about clinical manifestations, laboratory findings, and disease course was collected. In cases where the diagnosis was questionable, three rheumatologists reviewed all of the medical information and reached a consensus. The medical records of all patients from the previous study (1950 to 1985) were also reviewed [3], and the two data sets were collated. The diagnoses of giant cell arteritis and polymyalgia rheumatica were made according to the 1990 American College of Rheumatology criteria [5] and the criteria of Chuang and colleagues [6], respectively. Only persons who had been residents of Olmsted County for at least 12 months before the diagnosis of giant cell arteritis were included as incidence cases.

Age- and sex-specific incidence rates were calculated using the number of incidence cases as the numerator and population estimates based on decennial census counts as the denominator; linear interpolation was used to estimate population counts for years between censuses. Overall rates were age- and sex-adjusted to the 1980 United States white population. Ninety-five percent CIs were computed for incidence rates. The annual incidence rates were graphically illustrated using a 3-year centered moving average to eliminate some of the random fluctuation over time. The month of onset of the first symptoms related to giant cell arteritis was used to calculate the season-specific incidence rates. A generalized linear model [7] with log-link function and Poisson error structure was used to evaluate the relation between log incidence (the dependent variable) and age, sex, and chronologic time (in 5-year intervals), two-way interaction terms, and higher-order polynomial terms for age and time. The models were fit using GLIM (Generalized Linear Interactive Modelling). The observations used for the regression analysis were the crude incidence rates for both sexes in the following age groups: 50 to 59 years, 60 to 69 years, 70 to 79 years, and 80 or more years; and in the following calendar time periods: 1950-1954, 1955-1959, 1960-1964, 1965-1969, 1970-1974, 1975-1979, 1980-1984, and 1985-1991. The midpoints of the age groups and the calendar time periods were used in the trend analysis.


Results
space
up arrowTop
up arrowMethods
dotResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

Between 1950 and 1991, 125 Olmsted County residents (103 women and 22 men) were diagnosed with giant cell arteritis. Of these, 81 (64.8%) had giant cell arteritis alone and 44 (35.2%) also had polymyalgia rheumatica. One hundred and fifteen (92%) had positive temporal artery biopsies, and all fulfilled the 1990 American College of Rheumatology criteria for giant cell arteritis [5].

Table 1 shows the age- and sex-specific incidence rates, the overall age-adjusted rates for each sex, and these same age-adjusted rates according to time periods. The best generalized linear model analysis of predictors of incidence showed a significant elevation of incidence in women compared with men (P < 0.0001), a significant increase with age (P < 0.0001), and a significant linear effect of calendar time (P = 0.002). This calendar-time effect predicted a 2.6% increase in incidence every 5 years (CI, 0.9% to 4.3%).


View this table:
[in this window]
[in a new window]
 
Table 1. Incidence of Giant Cell Arteritis in Residents of Olmsted County, Minnesota, 1950-1991

 
Figure 1 shows the annual incidence rates per 100 000 persons 50 years of age or more between 1950 and 1991. Cases appear to have clustered in five peak periods (1953-1955, 1959-1961, 1967-1969, 1974-1976, and 1982-1984), each of which lasted about 3 years. The peaks in this cyclic pattern occurred approximately every 7 years. At every peak, the incidence rate was more than twice the previous level. Plots of the deviance residuals, taken from the generalized linear model, over time did not show a deviation from the linear trend. However, the relatively small number of incidence cases provided us with limited statistical power to detect important nonlinear trends. The trends in incidence among men and women were similar except during the earlier time periods, 1950-1970. The irregular fluctuations seen in men between 1950 and 1970 cannot be interpreted due to the small number of cases (n = 4) diagnosed among men during this time.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. Annual incidence rates of giant cell arteritis in Olmsted County, Minnesota, per 100 000 persons 50 years of age or older. Rates were calculated using a centered 3-year moving average.

 
Plots of the annual incidence rates per 100 000 persons 50 years of age or more showed that, among patients with giant cell arteritis but not polymyalgia rheumatica (n = 81), the five peaks remain clearly delineated. In fact, these peaks were somewhat less evident among patients with giant cell arteritis and polymyalgia rheumatica. Differences in season-specific incidence rates were not statistically significant.


Discussion
space
up arrowTop
up arrowMethods
up arrowResults
dotDiscussion
down arrowAuthor & Article Info
down arrowReferences

Our results, which show that giant cell arteritis is more common in women and in persons more than 70 years of age Table 1, confirm the results of earlier studies [8, 9]. We show a statistically significant increase in the incidence of giant cell arteritis over the study period Table 1, but heightened physician awareness and surveillance may account for this. However, our most remarkable finding was the apparent cyclic fluctuation in the incidence rate over the 42-year study period. This observation has not been previously reported. A regular repeating cyclic pattern in the development of giant cell arteritis over the 42-year period was apparent, with peaks appearing at intervals of about 7 years and lasting about 3 years. Although it seems unlikely that this regular cyclic pattern of incidence rates is random, we could not detect a statistically significant cyclic pattern. To suggest that this pattern is due to differences in disease ascertainment would imply alternating periods of high and low ascertainment; this is not plausible. The diagnosis in most cases (92%) was confirmed by temporal artery biopsy, making overascertainment unlikely. Furthermore, most physicians at our institution are very familiar with the presenting manifestations of giant cell arteritis, and rheumatologic consultation is readily available. Finally, the patients were identified using the medical records linkage system of the Mayo Clinic, which ensures almost complete ascertainment of all cases of any disease diagnosed in Olmsted County dating back 75 years [4]. The cyclic pattern is somewhat less evident in men than in women; this is probably due to the much smaller number of cases occurring among men. The cyclic pattern is also less evident among patients with giant cell arteritis and coexistent polymyalgia rheumatica than among those with giant cell arteritis alone. The exact nature of the relation between giant cell arteritis and polymyalgia rheumatica is uncertain. The differences we observed may reflect an unknown additional factor or factors that influence the development of polymyalgia rheumatica in patients with giant cell arteritis.

Illnesses with cyclic frequencies are most often infectious. An infectious cause has been previously postulated for giant cell arteritis and polymyalgia rheumatica [1, 10, 11]. Several reports of conjugal cases have been described and interpreted as evidence of a possible infectious cause [12-14]. Also, the presence of antibodies to intermediate filaments in patients with polymyalgia rheumatica or giant cell arteritis may indicate a viral cause [15] because these antibodies have also been found in serum specimens from patients with viral diseases [16]. Like giant cell arteritis [3, 17-23], other conditions (such as multiple sclerosis) that are suspected of having a viral cause have been noted to have an increased incidence at higher latitudes [24]. This implicates an environmental cause, in particular an infectious agent, that operates with increasing effectiveness or is more common at northern latitudes.

We have shown a statistically significant increase in the incidence of giant cell arteritis over the past four decades. Moreover, ours is the first study to report a regular cyclic pattern in giant cell arteritis incidence rates over time. We wish to emphasize, however, that although these results are intriguing, they are hypothesis-generating, and similar studies in other populations are needed to confirm our observations. Nonetheless, our findings support the hypothesis of an infectious cause for giant cell arteritis, perhaps in a genetically predisposed host. We hope that our data will serve as a stimulus for further research into the cause of this condition.


Author and Article Information
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
dotAuthor & Article Info
down arrowReferences

From Mayo Clinic and Mayo Foundation, Rochester, Minnesota.
Requests for Reprints: Sherine E. Gabriel, MD, MSc, Department of Health Sciences Research, Mayo Clinic, 200 First Street SW, Rochester, MN 55905.
Acknowledgments: The authors thank Mr. Eric Metz for assistance with statistical analysis and Ms. Lori Norby for assistance in manuscript preparation.
Grant Support: In part by research grant AR 30582 from the National Institutes of Health, United States Public Health Service.


References
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAuthor & Article Info
dotReferences

1. Fessel WJ. Polymyalgia rheumatica, temporal arteritis, and contact with birds. Lancet. 1969; 2:1249-50.

2. O'Brien JP, Regan W. Are we losing focus on the internal elastic lamina in giant cell arteritis? Arthritis Rheum. 1992; 35:794-8.

3. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum. 1988; 31:745-9.

4. Kurland LT, Molgaard CA. The patient record in epidemiology. Sci Am. 1981; 245:54-63.

5. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990; 33:1122-8.

6. Chuang TY, Hunder GG, Ilstrup DM, Kurland LT. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982; 97:672-80.

7. McCullagh P, Nelder JA. Generalized Linear Models. 2d ed. London: Chapman and Hall; 1989.

8. Huston KA, Hunder GG, Lie JT, Kennedy RH, Elveback LR. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. Ann Intern Med. 1978; 88:162-7.

9. Bengtsson BA, Malmvall BE. Giant cell arteritis. Acta Med Scand Suppl. 1982; 658:1-102.

10. Elling H, Skinhoj P, Elling P. Hepatitis B virus and polymyalgia rheumatica: a search for HBsAg, HBsAb, HBcAb, HBeAg, and HBeAb. Ann Rheum Dis. 1980; 39:511-3.

11. Cimmino MA, Grazi G, Balistreri M, Accardo S. Increased prevalence of antibodies to adenovirus and respiratory syncytial virus in polymyalgia rheumatica. Clin Exp Rheumatol. 1993; 11:309-13.

12. Mathewson JA, Hunder GG. Giant cell arteritis in two brothers. J Rheumatol. 1986; 13:190-2.

13. Barrier JH, Brisseau JM, Lucas V, Maugard-Louboutin C, Groleau J, Grolleau JY. Giant cell arteritis in a conjugal pair (Letter). J Rheumatol. 1988; 15:383-4.

14. Hickstein DD, Gravelyn TR, Wharton M. Giant cell arteritis and polymyalgia rheumatica in a conjugal pair. Arthritis Rheum. 1981; 24:1448-50.

15. Dasgupta B, Duke O, Kyle V, Macfarlane DG, Hazleman BL, Panayi GS. Antibodies to intermediate filaments in polymyalgia rheumatica and giant cell arteritis: a sequential study. Ann Rheum Dis. 1987; 46:746-9.

16. Toh BH, Yildiz A, Sotelo J, Osung O, Holborow EJ, Kanakoudi F, et al. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol. 1979; 37:76-82.

17. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. Arthritis Rheum. 1987; 30:294-9.

18. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol. 1992; 19:273-6.

19. Nordborg E, Bengtsson BA. Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med. 1990; 227:233-6.

20. Friedman G, Friedman B, Benbassat J. Epidemiology of temporal arteritis in Israel. Isr J Med Sci. 1982; 18:241-4.

21. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez-Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol. 1992; 19:277-80.

22. Salvarani C, Macchioni PL, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991; 34:351-6.

23. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis. Report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum. 1983; 26:1214-9.

24. Warren S. Epidemiology of multiple sclerosis. In: Anderson DW, Schoenberg DG, eds. Neuroepidemiology: A Tribute to Bruce Schoenberg. Boca Raton: CRC Press; 1991:239-64.


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
J Askling, L Klareskog, H Hjalgrim, E Baecklund, M Bjorkholm, and A Ekbom
Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis
Ann Rheum Dis, December 1, 2005; 64(12): 1765 - 1768.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F Perfetto, A Moggi-Pignone, A Becucci, F Cantini, M Di Natale, R Livi, A Tempestini, and M Matucci-Cerinic
Seasonal pattern in the onset of polymyalgia rheumatica
Ann Rheum Dis, November 1, 2005; 64(11): 1662 - 1663.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
R Alvarez-Lafuente, B Fernandez-Gutierrez, J A Jover, E Judez, E Loza, D Clemente, J A Garcia-Asenjo, and J R Lamas
Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction
Ann Rheum Dis, May 1, 2005; 64(5): 780 - 782.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J M Calvo-Romero
Giant cell arteritis
Postgrad. Med. J., September 1, 2003; 79(935): 511 - 515.
[Abstract] [Full Text]


Home page
LupusHome page
M Ramos-Casals, M Garcia-Carrasco, M P Brito, A Lopez-Soto, and J Font
Autoimmunity and geriatrics: clinical significance of autoimmune manifestations in the elderly
Lupus, May 1, 2003; 12(5): 341 - 355.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
C. Nordborg, H. Johansson, V. Petursdottir, and E. Nordborg
The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the population
Rheumatology, April 1, 2003; 42(4): 549 - 552.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Nordborg and C. Nordborg
Giant cell arteritis: epidemiological clues to its pathogenesis and an update on its treatment
Rheumatology, March 1, 2003; 42(3): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Salvarani, F. Cantini, L. Boiardi, and G. G. Hunder
Polymyalgia Rheumatica and Giant-Cell Arteritis
N. Engl. J. Med., July 25, 2002; 347(4): 261 - 271.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Reinhold-Keller, K. Herlyn, R. Wagner-Bastmeyer, J. Gutfleisch, H. H. Peter, H. H. Raspe, and W. L. Gross
No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register
Rheumatology, May 1, 2002; 41(5): 540 - 549.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. Helweg-Larsen, B. Tarp, N. Obel, and B. Baslund
No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis
Rheumatology, April 1, 2002; 41(4): 445 - 449.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. W. Smetana and R. H. Shmerling
Does This Patient Have Temporal Arteritis?
JAMA, January 2, 2002; 287(1): 92 - 101.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M A Gonzalez-Gay, C Garcia-Porrua, M J Rivas, P Rodriguez-Ledo, and J Llorca
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period
Ann Rheum Dis, April 1, 2001; 60(4): 367 - 371.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
E. Reinhold-Keller, A. Zeidler, J. Gutfleisch, H. H. Peter, H. H. Raspe, and W. L. Gross
Giant cell arteritis is more prevalent in urban than in rural populations: results of an epidemiological study of primary systemic vasculitides in Germany
Rheumatology, December 1, 2000; 39(12): 1396 - 1402.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
D. G I SCOTT and R. A WATTS
Systemic vasculitis: epidemiology, classification and environmental factors
Ann Rheum Dis, March 1, 2000; 59(3): 161 - 163.
[Full Text]


Home page
Rheumatology (Oxford)Home page
V. Petursdottir, H. Johansson, E. Nordborg, and C. Nordborg
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations
Rheumatology, December 1, 1999; 38(12): 1208 - 1212.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
S E Gabriel
The epidemiology of gender-discrepant Illness
Lupus, June 1, 1999; 8(5): 339 - 345.
[PDF]


Home page
Ann Rheum DisHome page
P. Duhaut, L. Pinède, H. Bornet, S. Demolombe-Ragué, C. Dumontet, J. Ninet, R. Loire, and J. Pasquier
Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease
Ann Rheum Dis, June 1, 1999; 58(6): 335 - 341.
[Abstract] [Full Text]


Home page
JAMAHome page
L. K. Gordon and L. A. Levin
Visual Loss in Giant Cell Arteritis
JAMA, July 22, 1998; 280(4): 385 - 386.
[Full Text] [PDF]


Home page
LupusHome page
G G Hunder
Giant cell arteritis
Lupus, May 1, 1998; 7(4): 266 - 269.
[Abstract] [PDF]


Home page
NEJMHome page
G. G. Hunder and C. M. Weyand
Sonography in Giant-Cell Arteritis
N. Engl. J. Med., November 6, 1997; 337(19): 1384 - 1386.
[Full Text]


Home page
Ann Rheum DisHome page
C. VITALI, E. GALLUZZO, E. M CIANCIA, A. MORETTI, and S. MARCHI
Giant cell arteritis of the leg in a patient with hepatitis C virus infection
Ann Rheum Dis, November 1, 1997; 56(11): 697 - 698.
[Full Text]


Home page
Ann Rheum DisHome page
M. A CIMMINO
Genetic and environmental factors in polymyalgia rheumatica
Ann Rheum Dis, October 1, 1997; 56(10): 576 - 577.
[Full Text]


box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Salvarani, C.
space
  arrow  Hunder, G. G.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online